<DOC>
	<DOCNO>NCT02418923</DOCNO>
	<brief_summary>This study compare result current standard coagulation measurement device Quantra System , new device , use small amount extra blood obtain routine blood draw neurosurgery patient .</brief_summary>
	<brief_title>HemoSonics-UVA Spinal Surgery</brief_title>
	<detailed_description>HemoSonics develop novel POC diagnostic device , Quantra System , perform whole blood coagulation analysis suitable use surgical intensive care setting . The Quantra System employ patented technology name sonorheometry , invent University Virginia . Sonorheometry use ultrasound pulse characterize dynamic change viscoelastic property blood sample coagulation clot lysis . The initial assay perform Quantra System surgical assay monitor hemostasis major surgical procedure adult patient . A clinical study conduct evaluate analytical performance well compare exist coagulation monitoring technology</detailed_description>
	<criteria>• Subject schedule major deformity correction spine surgery Subject old 18 year Subject willing participate he/she sign consent form • Subject unable provide write informed consent Subject incarcerate time study Subject affect condition , opinion surgical team , may pose additional risk Subjects renal disease ( define serum creatinine great 1.5 mg/dl ) Subjects history active liver disease Subjects affect Factor V Leiden mutation Subjects affect von Willebrand disease Subjects history thrombotic disease ( one DVT )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>